MyOme Launches Integrated Risk Tool for Coronary Artery Disease MENLO PARK, Calif., Feb. 27, 2025 /PRNewswire/ -- MyOme, Inc., a…
Metabolon's expertise extends beyond metabolomics to include data insights and software solutions for multiomics research MORRISVILLE, N.C., Feb. 27, 2025…
SpherePX Technology Powers Early Detection and Personalized PreventionFRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Alira Health, a global healthcare…
PALO ALTO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Orbus Therapeutics, Inc., a private, late-stage biopharmaceutical company focused on the…
MALVERN, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader…
The Clinical Study is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites…
From Integrating Real-Time Pharmacogenomics to Boosting Medication Adherence, Healthcare Organizations Are Realizing the Benefits of Advanced Medication Decision Support SOUTH…
Pivotal Study Data Show Comparable "Gold Standard" Efficacy to Traditional Sacral Neuromodulation (SNM) Devices – Eliminating Burdens of a Battery…
HOUSTON, Feb. 26, 2025 /PRNewswire/ -- Avance Biosciences, a leading provider of high-quality analytical and bioanalytical services for the pharmaceutical…
NEW YORK, Feb. 26, 2025 /PRNewswire/ -- Let's Win Pancreatic Cancer proudly announces our enhanced patient-centered navigation and two powerful new…